Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity

Pain

Volumn 83, Issue 2, 1999, Pages 137-145

  Atkinson, J Hampton ^a,c   Slater, Mark A ^b,c,e   Wahlgren, Dennis R ^b,d   Williams, Rebecca A ^b   Zisook, Sidney ^a,c   Pruitt, Sheri D ^b   Epping Jordan, Joanne E ^b   Patterson, Thomas L ^a,c   Grant, Igor ^a,c   Abramson, Ian ^a   Garfin, Steven R ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN DIEGO STATE UNIVERSITY   (United States)

^e Sharp Hlthcare and Res Foundation   (United States)

Author keywords

Analgesia; Antidepressants; Back pain

Indexed keywords

ANALGESIC AGENT; DIPHENHYDRAMINE; MAPROTILINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART PALPITATION; HUMAN; INSOMNIA; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MOOD; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SWEATING; THORAX PAIN; XEROSTOMIA;

ADRENERGIC UPTAKE INHIBITORS; ADULT; AGED; CHRONIC DISEASE; DIPHENHYDRAMINE; DOUBLE-BLIND METHOD; HUMANS; HYPNOTICS AND SEDATIVES; LOW BACK PAIN; MAPROTILINE; MIDDLE AGED; PAIN MEASUREMENT; PAROXETINE; PATIENT SELECTION; PLACEBOS; SEROTONIN UPTAKE INHIBITORS;

EID: 0032858771     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00082-2     Document Type: Article

References (50)

1. Alcoff J., Jones E., Rust P., Newman R. Controlled trial of imipramine for chronic low back pain. J. Fam. Pract. 14:1982;841-846.
2. Atkinson J.H., Slater M.A., Williams R.A., Zisook S., Patterson T.L., Grant I., Wahlgren D.R., Abramson I., Garfin S.R. A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain. 76:1998;287-296.
3. Atkinson J.H., Slater M.A., Patterson T.L., Grant I., Garfin S.R. Prevalence, onset, and risk of psychiatric disorders in men with chronic low back pain: A controlled study, Pain. 45:1991;111-121.
4. Beck A.T. Depression: Clinical, experimental and theoretical aspects. 1967;Hoeber, New York.
5. Beck A.T., Steer R.A., Garbin M.G. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev. 1988;77-100.
6. Broadhead W.E., Larson D.B., Yarnall K.S.H., Blazer D.G., Tsc C.K.J. Tricyclic antidepressants prescribing for non-psychiatric disorder. An analysis based on data from the National Ambulatory Medical Care Survey. J Fam Pract. 33:1991;24-32.
7. Deyo R.A. Conservative therapy for low back pain: distinguishing useful from useless therapy. J Am Med Assoc. 250:1983;1057-1062.
8. Deyo R.A., Diehl A.K. Measuring physical and psychosocial function in patients with low back pain. Spine. 8:1983;635-642.
9. Doctor J.N., Slater M.A., Atkinson J.H. The descriptor differential scale of pain intensity: An evaluation of item and scale properties. Pain. 61:1995;251-260.
10. Fawcett J., Epstein P., Fiester S.J., Elkin I., Autry J.H. Clinical management-imipramine/placebo administration manual: NIMH Treatment of Depression Collaborative Research Program. Psychopharm Bull. 23:1987;309-324.
11. France R.D., Krishnan K.R.R. Chronic pain. 1988;American Psychiatric Association Press, Washington, DC.
12. Frank E., Kupfer D.J., Perel J.M., Cornes C., Jarrett D.B., Mallinger A.G., Thase M.E., McEachran A.B., Grochocinski V.J. Three year outcomes for maintenance therapyies in recurrent depression. Arch Gen Psychiatry. 47:1990;1093-1099.
13. Goodkin K., Gullion C.M. Antidepressants for the relief of chronic pain: Do they work? Annu Behav Medicine. 11:1989;83-101.
14. Goodkin K., Gullion C.M., Agras W.S. A randomized, double-blind placebo controlled trial of trazodone hydrochloride in chronic low back pain syndrome. J Clin Psychopharm. 10:1990;269-278.
15. Gracely R.H., Kwilosz D.M. The descriptor differential scale: applying psychophysical principles to clinical pain assessment. Pain. 35:1988;279-288.
16. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 32:1959;50-55.
17. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
18. Hamilton M. General problems of psychiatric rating scales (especially for depression). Mod Prob Pharmacother. 7:1974;125-138.
19. Janicak P.G., Davis J.M., Preskorn S.H., Ayd F.J. Jr. Principles and practice of psychopharmacotherapy. 1993;Williams and Wilkins, Baltimore.
20. Jenkins D.G., Ebbutt A.F., Evans C.D. Tofranil in the treatment of low back pain. J Int Med Res. 4:(S2):1976;28-40.
21. Kishore-Kumar R., Max M.B., Schafer S.C., Gaughan A.M., Smoller B., Gracely R.H., Dubner R. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther. 47:1990;305-312.
22. Krishnan K.R.R., France R.D., Pelton S., McCann U.D., Davidson J., Urban B.J. Chronic pain and depression I: Classification of depression in chronic low back pain patients. Pain. 22:1985;289-294.
23. Kvinesdal B., Molin J., Froland A., Gram L.F. Imipramine treatment of painful diabetic neuropathy. J Am Med Assoc. 251:1984;1727-1730.
24. Max M.B. Antidepressants as analgesics. Fields H.L., Liebeskind John C. Progress in pain research and management. 1:1994;229-246 IASP Press, Seattle.
25. Max M.B., Culnane M., Schafer S.C., Gracely R.H., Walther D.J., Smoller B., Dubner R. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 37:1987;589-596.
26. Max M.B., Kishore-Kumar R., Schafer S.C., Meister B., Gracely R.H., Smoller B., Dubner R. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain. 45:1991;3-9.
27. Max M.B., Lynch S.A., Muir J., Shoaf S.E., Smoller B., Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 326:1992;1250-1256.
28. Max M.B., Schafer S.C., Culnane M., Smoller B., Dubner R., Gracely R.H. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia, Neurology. 38:1988;427-1432.
29. Moscucci M., Byrne L., Weintraub M., Cox C. Blinding, unblinding, and the placebo effect: an analysis of patients' guesses of treatment assignment in a double-blind clinical trial. Clin Pharmacol Ther. 41:1987;259-265.
30. Norusis M.J. SPSS/PC+ and base system's user's guide, Version 5.0. 1992;SPSS, Chicago.
31. Onghena P., Van Houdenhove B. Antidepressant induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain. 49:1992;205-219.
32. Pheasant H., Bursk A., Goldfarb J., Azen S.P., Weiss J.N., Borelli L. Amitriptyline and chronic low back pain. Spine. 8:1983;552-557.
33. Rabkin J.G., Markowitz J.S., Ocepek-Welikson K., Wagner S. General versus systemic inquiry about medication side-effects with SAFTEE: Implications for clinical research. J Clin Psychopharmacol. 12:1992;3-10.
34. Richelson E. The pharmacology of antidepressants at the synapse: focus on newer compounds. J Clin Psychiatry. 55:1994;34-39.
35. Richelson E. Synaptic effects of antidepressants. J Clin Psychopharmacol. 16:(Suppl 2):1996;1S-7S.
36. Sindrup S.H., Gram L.F., Skjold T., Froland A., Beck-Nielsen H. Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms. Clin Pharmacol Ther. 47:1990;509-515.
37. Sindrup S.H., Gram L.F., Brosen K., Eshoj O., Mogensen E.F. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain. 42:1990;135-144.
38. Sindrup S.H., Grodum E., Gram L.F., Beck-Nielsen H. Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: a patient-blinded dose escalation study. Ther Drug Monitoring. 13:1991;408-414.
39. Spiegel K., Kalb R., Pasternak W. Analgesic activity of tricyclic antidepressants. Annu Neurol. 13:1983;462-465.
40. Spielberger C.D., Gorsuch R.L., Lushene R.E. STAI manual for the state-trait anxiety inventory. 1969;Consulting Psychologists Press, Palo Alto, CA.
41. Spitzer R., Williams J., Gibbons M., First M. Structured clinical interview for DSM III R (non-patient version). 1990;American Psychiatric Association, Washington, DC.
42. Spitzer W.O., LeBlanc F.E., Dupuis M. Scientific approach to the assessment and management of activity-related spinal disorders. Spine. 12:1987;S1-59.
43. Turner J.A., Denny M.C. Do antidepressant medications relieve chronic low back pain? J Fam Pract. 37:1993;545-553.
44. Turner J.A., Deyo R.A., Loeser J.D., VonKorff M., Fordyce W.E. The importance of placebo effects in pain treatment and research. J Am Med Assoc. 271:1994;1609-1614.
45. Waddell G., Main C.J. Assessment of severity in low back disorders. Spine. 9:1984;204-208.
46. Ward N.G. Tricyclic antidepressants for chronic low back pain. Spine. 11:1986;661-665.
47. Watson C.P.N., Chipman M., Reed K., Evans R.J., Birkett N. Amitriptyline versus maprotiline in post-herpetic neuralgia: a randomized, double blind, crossover trial, Pain. 48:1992;29-36.
48. Watson C.P., Evans R.J., Reed K., Merskey H., Goldsmith L., Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 32:1982;671-673.
49. Williams J.B.W. A structured interview for the Hamilton Depression Rating Scale. Arch Gen Psych. 45:1988;742-747.
50. Yaksh T.L., Al-Rodhan N.R.F., Jensen T.S. Sites of action of opiates in production of analgesia. Prog Brain Res. 77:1988;371-394.